Monitoring FSH levels to optimize ovarian stimulation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of serum Follicle Stimulating Hormone (FSH) levels in predicting oocyte yield and progesterone levels during ovarian stimulation. It considers various factors such as age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The goal is to identify a minimum FSH level that ensures optimal ovarian response, allowing for tailored FSH dosages to improve outcomes. By focusing on FSH monitoring, the study aims to enhance the effectiveness of ovarian stimulation protocols.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* regular 21 - 35 days cycles
* BMI between 19 - 30 kg/m2
* serum AMH level between 1.5 to 3 ng/ml
* a total antral follicle count between 10 to 24
* endogenous early follicular phase serum FSH level \<10 IU/L
* normal glomerular filtration rate

Exclusion Criteria:

* hypogonadotropic hypogonadism
* history of ovarian surgery
* permanent ovarian cysts of any form
* older than 39 years
* abnormal thyroid stimulating hormone (TSH)
* renal disease
* elevated prolactin levels
* intake of oral contraceptives 3 months before stimulation start and estradiol pretreatment will be excluded

Where it's running

• ART Fertility Clinics
  Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates Recruiting

Study contacts

• Study coordinator: Jonalyn Edades
• Email: jonalyn.edades@artfertilityclinics.com
• Phone: +971526408688

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-guided trigger timing to optimize egg retrieval in IVF

  This trial tests whether an AI program can guide monitoring and the ovulation trigger to produce similar or better IVF cycle results than decisions made by doctors.

  Recruiting Fundacion Dexeus · Sabadell, Barcelona and 4 other locations · NCT07515118

• Measuring follicular volume to improve oocyte maturation in women with low ovarian reserve

  This study is testing if measuring the size of ovarian follicles can help women with low egg supply get healthier eggs during fertility treatment.

  Recruiting ART Fertility Clinics LLC · Abu Dhabi, Abu Dhabi Emirate · NCT06839274

• rFSH versus hMG effects on cumulus cell telomere length and blastocyst development

  This trial will test whether using recombinant FSH (Gonal‑F) versus human menopausal gonadotropin (Menopur) during ovarian stimulation changes cumulus cell telomere length and later blastocyst outcomes in women 18–38 undergoing IVF with PGT‑A.

  Recruiting ART Fertility Clinics LLC · Abu Dhabi, Abu Dhabi Emirate · NCT06732843

• Progestin-primed ovarian stimulation with corifollitropin alfa versus standard rFSH/GnRH antagonist (crossover)

  This study will test whether progestin-primed ovarian stimulation using a single-dose corifollitropin alfa improves patient satisfaction and compliance while producing similar ovarian response compared with conventional recombinant FSH plus a GnRH antagonist in women having their first IVF/ICSI cycle for fertility pres

  Recruiting Phase 4 University Hospital, Ghent · Ghent · NCT06175832

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.